assessed the utility of beta blockade, a trend toward a positive effect was seen; however, the level of benefit of this approach failed to reach statistical significance. 25 This potential but unclear benefit is under further review, awaiting the results of the Randomized Evaluation of Beta Blocker and ACE-Inhibitor / Angiotensin Receptor Blocker Treatment in Patients with Myocardial Infarction with Non-Obstructive Coronary Arteries (MINOCA-BAT) trial. 26 Calcium channel blockers were one of the most prescribed medications for patients with INOCA, but not for patients with MINOCA.
← all excerpts
Unveiling the Longitudinal Journey: 3-Year Follow-up of Women with MINOCA and INOCA in a Specialized Heart Centre.
1
—
—